La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « H. A. Robertson »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
H. A. Mckay < H. A. Robertson < H. A. Shill  Facettes :

List of bibliographic references indexed by H. A. Robertson

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
002B12 (2005) V. F. Rafuse [Canada] ; P. Soundararajan [Canada] ; C. Leopold [Canada] ; H. A. Robertson [Canada]Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog
003489 (2000) M. O. Hebb [Canada] ; H. A. Robertson [Canada]Identification of a subpopulation of substantia nigra pars compacta γ‐aminobutyric acid neurons that is regulated by basal ganglia activity
003737 (1999) M. O. Hebb [Canada] ; H. A. Robertson [Canada]Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases
004014 (1995) M. L. Paul [Canada] ; R. W. Currie ; H. A. RobertsonPriming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity
004528 (1992) H. A. Robertson [Canada]Dopamine receptor interactions: some implications for the treatment of Parkinson's disease
004629 (1992) H. A. Robertson [Canada]Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease : sites of action and implications for the pathogenesis of dyskinesias
004630 (1992) H. A. Robertson [Canada] ; M. R. Peterson ; G. G. WorthSynergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243
004654 (1992) M. L. Paul [Canada] ; A. M. Graybiel ; J.-C. David ; H. A. Robertson [Canada]D1-like and D2-like dopamine receptors synergistically actitave rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease
004A59 (1989) G. S. Robertson [Canada] ; D. G. Herrera [Canada] ; M. Dragunow [Canada] ; H. A. Robertson [Canada]L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra
004B88 (1988) G. S. Robertson [Canada] ; H. A. Robertson [Canada]Evidence that the substantia nigra is a site of action for l-DOPA
004D22 (1987) G. S. Robertson [Canada] ; H. A. Robertson [Canada]D1 and D2 dopamine agonist synergism: separate sites of action?
004D90 (1987) H. A. Robertson ; G. S. RobertsonHypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action
004E19 (1986) H. A. Robertson [Canada] ; G. S. Robertson [Canada]The antiparkinson action of bromocriptine in combination with levodopa

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "H. A. Robertson" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "H. A. Robertson" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    H. A. Robertson
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022